Bayer, Onyx cancer treatment Nexavar falls short of main goal in late-stage lung cancer study
Yahoo/AP
Your Warning Label Is My Sales Brochure
Motley Fool
Bayer appeals India patent office ruling
MarketWatch
Diving for Dividend Growth in Big Pharma
Motley Fool
Top 10 late-stage cancer drugs in 2012
Fierce Biotech
FDA adds clotting data to Bayer's Yaz, Yasmin
Fierce Pharma

